top of page

Press Release Archive

ANP’s Polymeric Drug Excipient Drug Master File (DMF) Accepted and Published by the U.S. Food and Drug Administration (FDA)

Read more....

June 2, 2022

ANP’s NIDS® COVID-19 Antigen Rapid Test Kit Successfully Detects Omicron Variant

January 4, 2022

ANP Technologies, Inc. Publishes Its Study Titled "COVID-19 Neutralizing Antibody Surveillance Testing for Fully Vaccinated Individuals During Delta Variant Spread"

October 3, 2021

ANP Technologies, Inc. Receives FDA EUA Authorization for its NIDS® COVID-19 Antigen Rapid Test Kit

September 27, 2021

ANP Technologies and its Partner Fulgent Pharma Successfully Reached Targeted Therapeutic Dosage Level in Phase I Clinical Trial for Its Nano-Paclitaxel Drug

May 19, 2021

ANP Technologies®, Inc. Receives $19.7M from NIH/NIBIB/Rapid Acceleration of Diagnostics (RADx) Program for its NIDS® COVID-19 Antigen Rapid Test Kit

April 16, 2021

ANP Technologies, in Partnership with Fulgent Pharma, Teams with Moffitt Cancer Center to Develop a New Class of Leukemia Therapies

January 10, 2020

ANP Technologies, Inc. Renews its ISO9001:2015 Quality Management System Certification

March 8, 2019

ANP Technologies® Inc receives Innovators Award from Delaware Bioscience Association

April 20, 2018

The U.S. Food and Drug Administration (FDA) has granted approval for ANP Technologies, Inc. and its partner to begin Phase I clinical trials with its first drug – nanoencapsulated paclitaxel

February 27, 2018

U.S. Army Awarded ANP Technologies, Inc. a Continued ID/IQ Manufacturing contract for 2-plexed Toxin Handheld Assays

February 23, 2018

U.S. Army Awarded ANP Technologies Full-Fielding Contract of the NIDS® ACE sensor

February 10, 2018

ANP Awarded an Additional SBIR Phase III Contract to Further Develop its NIDS® ACE Sensor Platform for the U.S Army

May 15, 2017

ANP and Federal Resources (FR) Secure Multi-Million Dollar Contract with U.S. Air National Guard to Support Rapid Detection of Biological Threats via ANP’s Nano Intelligent Detection System (NIDS®)

January 5, 2017

Department of Defense Awards ANP a Large Contract to Develop Nano-Antibody Cocktail to Treat Ebola Infection

November 15, 2016

Army Small Business a Mission Enabler

August 8, 2016

Department of Defense Awards Water Monitoring Contract for Biotoxins to ANP

September 12, 2014​

National Guard Selects ANP as Premier Solution

August 20, 201​4

ANP Awarded Prestigious BIRD Grant

July 14, 2014

ANP Technologies Awarded Additional Phase III SBIR Funding

May 25, 2014

ANP Technologies Wins Second US DoD Phase III SBIR Award

March 20, 2013

NIDS Biothreat Detection System has been “Designated as a Qualified Anti-Terrorism Technology (QATT)”

March 17, 2013

Dr. Ray Yin to Moderate Hot Topic Discussion on Immunogenicity at AAPS

May 18, 2012

ANP Technologies Receives National Tibbetts Award 2011

February 15, 2011

ANP Technologies’ Founder Garners 2010 AAPS Excellence in Ligand Binding Assays Award

May 17, 2010

bottom of page